SCID is a heterogeneous group of genetic disorders characterized by profound defect of T-and B-cell function. SCID patients usually die in early childhood unless immune reconstitution by hematopoietic stem cell transplantation (HSCT) or gene therapy can be achieved. 1 The most common type of SCID is X-linked SCID (X-SCID), that is, T − B+NK − SCID, caused by mutations of the IL2RG gene. 2 The thymus of the X-SCID patients is atrophic due to the defect of T-cell differentiation in the early stage.
2 Sufficient T-cell reconstitution is usually obtained by HSCT even without chemotherapy conditioning in these patients over the long term. 3 Although these patients might not have significant numbers of multilineage stem cell engraftment, it can offer seeding of T-cell precursor niches sufficient to maintain thymopoiesis. 4, 5 HSCT without conditioning provides split chimerism, where T cells derive from the donor and B cells derive from the recipient, respectively, and the recovery of B-cell function is not usually obtained because of the intrinsic defect in recipient B-cell function. 6 Thus, many patients require Ig replacement therapy for life. 7 Chemotherapy conditioning can lead to the recovery of humoral immunity in this disease. However, conditioning for HSCT may cause severe life-threatening side effects, especially in early infancy.
CD3δ deficiency is a rare form of SCID (T − B+NK+). 8 Although CD3-deficient patients who received HSCT with or without chemotherapy conditioning have been reported, 9 it is not clear whether sufficient cellular and humoral immune reconstitution can be achieved after the HSCT without conditioning over long periods of time.
We performed cord blood transplantation (CBT) in two patients with CD3δ deficiency without conditioning. The patients had a homozygous CD3D gene mutation (c.275-2A4G). 10 Clinical data of the index patient and patient 1 of this study at the time of the diagnosis were reported previously.
9,10 Patients 1 and 2 (the younger brother of the patient 1) were diagnosed as having CD3δ deficiency at birth according to the family history, and underwent CBT at 30 and 25 days after birth, respectively. Both the patients were transplanted with human leukocyte Ags 6/6 matched cord blood mononuclear cells (4.0 × 10 7 cells per kg in patient 1 and 24.7 × 10 7 cells per kg in patient 2). They had no complications other than mild and transient acute skin GvHD, which resolved spontaneously.
T-cell reconstitution was obtained partially in both the patients early after transplantation. On a long-term basis, the T-cell numbers of the patients were below the normal range (o1000 cells per μl; Figure 1a) . Interestingly, the CD8 + T-cell numbers were extremely low for several years after transplantation in both the patients. Proliferative response of peripheral blood cells to PHA reached a normal level only transiently (Figure 1b ). Vβ repertoire of peripheral blood T cells showed normal distribution (data not shown). Patients 1 and 2 have been suffering from verruca vulgaris on their hands and feet since 5 and 3 years after transplantation, respectively, suggesting insufficient cellular immune function clinically. The sjTREC (signal joint TCR recombination excision circle) copy numbers 11 of the patients 1 and 2 investigated 10 and 5 years after transplantation, respectively, were below the detection limit (Figure 1c) , and the CD45RA + naive T cells shared a very small population in the total T cells (Figure 1d ) in both the patients. These results indicated a markedly decreased thymic output even after CBT.
Serum IgG production levels were within the normal range since an early post-transplantation period in both patients (Figure 2a ). Influenza immunization induced significant serum anti-influenza virus type A (H1N1) Ab titers 5 and 3 years after transplantation in patients 1 and 2, respectively ( Figure 2b) . The B-cell numbers and sjKREC (signal joint kappa-deleting recombination excision circle) copy numbers were within the normal range before and after transplantation in both the patients (data not shown).
We analyzed the origin of B cells after CBT. After purification of T cells and B cells by magnetic beads, the chimerism analysis was performed by FISH using directly labeled probes for the X and Y chromosomes. Five hundred of 500 cells (100%) of purified B cells were recipient-derived (XX type) cells (data not shown).
The chemotherapy conditioning for HSCT in patients with SCID is still controversial. Conditioning for HSCT may assure higher rate of engraftment, but can cause severe life-threatening side effects, especially in early infants. This is the first report that investigated the immunological recovery over long periods of time after HSCT without conditioning in CD3δ-deficient patients. Although T-cell engraftment was achieved in both the patients, the peripheral blood T-cell numbers were subnormal and were on a decline after HSCT in our patients (Figure 1a) . We found that the insufficient T-cell reconstitution was due to the decreased thymus-dependent T-cell regeneration (Figures 1c and d) . Severe GvHD, that is one of the causes of insufficiency of thymus-dependent T-cell regeneration, 12 did not occur in either patient. T-cell reconstitution might be heavily dependent on thymus-independent peripheral expansion of mature T cells derived from transplanted cord blood in these patients. 13 It was reported that maturational arrest at the CD4 − CD8 − double-negative stage and the accumulation of these cells were observed in the thymus of patients with CD3δ deficiency. 8 Actually, the thymi of our patients were not atrophic, but can be detected with appropriate size before HSCT. Therefore, it is possible that the T-precursor niche is occupied by the recipient cells, which might result in the competition during the process of donor T-cell maturation. Our results are in line with the report by Hassan et al., 14 which indicated that NK + SCID was less permissive for donor T-cell engraftment and the peripheral blood T-cell numbers were significantly lower in NK + SCID patients than in NK − SCID patients after HSCT without conditioning. They suggested that the thymus with recipient T-cell precursors might affect the process of T-cell reconstitution after HCST without conditioning. Furthermore, they showed that the event-free survival of NK + SCID patients were significantly lower than NK − SCID patients (42% vs 81%). The other possibility is that recipient natural killer (NK) cells might suppress donor T-cell reconstitution.
14 It is possible that NK cells had a suppressive role more potently against CD8 + T cells than CD4 + T cells during the early periods after transplantation (Figure 1a) .
In this study, we observed a functional humoral immunity in spite of the split chimerism after transplantation in both the patients against influenza vaccine, which suggested appropriate interaction of donor-derived T cells and CD3δ-deficient patientderived B cells. Although the patients' cellular immunity levels have been subnormal, they have not experienced severe infectious disorders other than verruca vulgaris and upper respiratory infections only several times a year suggesting recovery of humoral immunity at least partially. The recent progress on the newborn screening for SCID expanded opportunities for the patients to receive HSCT during an earlier age than before. CD3δ-deficient patients without infectious disorders or other risk factors are recommended to receive HSCT with chemotherapy conditioning to achieve sufficient cellular immunity for long periods. 
